Is Atossa Genetics Inc (ATOS) overvalued? · $121.2M cap
Atossa Genetics Inc (ATOS) is a biotechnology company listed on US.
This page asks whether Atossa Genetics Inc (ATOS) looks expensive on cached numbers — not a short thesis.
No cached income statement for ATOS, so there is no earnings base to call rich or cheap.
ATOS currently screens at market cap $121.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ATOS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ATOS stock page for the full model, not this heading.
Not investment advice.